Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Nippon Shikizai

Kawaguchi Chemical Industry

KAWAKAMI PAINT MFG.

RaQualia Pharma

シンバイオ製薬

Sosei Group

Carna Biosciences

日本化学工業

廣貫堂

Chiome Bioscience

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Renesas Electronics

PIONEER etc.

NIPPON COKE & ENGINEERING

KIKUSUI ELECTRONICS etc.

KIKUSUI ELECTRONICS etc.

Financial Indicator Details: RaQualia Pharma (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: RaQualia Pharma (Annual )

Non-Consolidated :Indicator Non-Consolidated

Profitability	2011-12-31	2012-12-31
Net profit margin (Industry Average)	-280.11% (-10.69%)	-10,375.00% (8.92%)
C/F margin (Industry Average)	-232.45% (-0.81%)	-9,742.85% (-39.63%)
ROA (Industry Average)	-22.86% (-0.27%)	-52.80% (1.53%)
ROE (Industry Average)	-23.44% (3.42%)	-54.70% (2.62%)
Growth	2011-12-31	2012-12-31
Equity growth (Industry Average)	- (0.04%)	-35.03% (3.91%)
Sales growth (Industry Average)	- (-)	-95.90% (-1.74%)
Net profit growth (Industry Average)	- (-47.04%)	-51.61% (62.14%)
Operating C/F growth (Industry Average)	- (-44.41%)	-71.57% (46.89%)
Stability	2011-12-31	2012-12-31
Capital adequacy (Industry Average)	97.55% (55.93%)	96.52% (57.57%)
Liquidity ratio (Industry Average)	3,802.78% (314.47%)	2,774.47% (233.84%)
C/F ratio current liabilities (Industry Average)	-12.87% (76.77%)	-6.72% (31.87%)
Quick ratio (Industry Average)	3,749.23% (228.06%)	2,670.73% (169.77%)
Turnover	2011-12-31	2012-12-31
Receivables turnover (Industry Average)	0.72day (98.58day)	124.62day (67.18day)
Inventory turnover (Industry Average)	24.07day (50.67day)	622.50day (38.21day)
Payable turnover (Industry Average)	- (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	24.79day (95.69day)	747.12day (71.15day)
Stock etc.	2011-12-31	2012-12-31
Market Value growth (Industry Average)	- (-3.30%)	- (24.19%)
Dividend Yield (Industry Average)	- (0.16%)	- (0.15%)
PER (Industry Average)	- (22.26%)	- (26.42%)
PBR (Industry Average)	- (1.08%)	- (1.54%)
PCFR (Industry Average)	- (0.08%)	- (4.97%)
PSR (Industry Average)	- (4.37%)	- (10.14%)

Financial Indicator Details: RaQualia Pharma

Non-Consolidated :Indicator Non-Consolidated

Indicator	2011-12-31	2012-12-31
Profitability
Net profit margin	-280.11%	-10,375.00%
C/F margin	-232.45%	-9,742.85%
ROA	-22.86%	-52.80%
ROE	-23.44%	-54.70%
Recurring margin	-278.65%	-10,325.00%
EBIT margin	-279.04%	-10,377.63%
EBITDA margin	-276.22%	-10,276.45%
NOPAT margin	-167.42%	-6,226.58%
Sales SG rates	381.60%	9,529.55%
Sales SG&A rates	-	-
Sales R&D expenses rates	-	-
Sales depreciation rates	2.81%	101.18%
Capital expenditures net sales ratio	-0.98%	-187.06%
Indicator	2011-12-31	2012-12-31
Growth
Growth rate of cash	-	-36.26%
Equity growth	-	-35.03%
Total assets growth	-	-34.34%
Sales growth	-	-95.90%
Net profit growth	-	-51.61%
Operating C/F growth	-	-71.57%
Recurring profit growth	-	-51.67%
EBIT growth	-	-52.24%
EBITDA growth	-	-52.29%
NOPAT growth	-	-52.24%
Operating expenses growth	-	-
Indicator	2011-12-31	2012-12-31
Stability
Capital adequacy	97.55%	96.52%
Liquidity ratio	3,802.78%	2,774.47%
C/F ratio current liabilities	-12.87%	-6.72%
Quick ratio	3,749.23%	2,670.73%
Fixed ratio	0.83%	1.90%
D/E ratio	-	-
Loan to Value Ratio	-	-
Business investment C/F ratio	0.42%	1.92%
Liabilities with interest growth	-	-
Indicator	2011-12-31	2012-12-31
Turnover
Cash turnover	4,094.14day	63,744.49day
Receivables turnover	0.72day	124.62day
Inventory turnover	24.07day	622.50day
Fixed assets turnover	36.46day	1,320.57day
Total asset turnover	4,471.32day	71,711.21day
Payable turnover	-	-
Capital turnover	4,530.40day	110,671.25day
Equity turnover	4,361.85day	69,219.64day
Working capita turnover	24.79day	747.12day
Indicator	2011-12-31	2012-12-31
Balance sheet
Cash etc.	¥ 7 B	¥ 4 B
Accounts receivable-trade	¥ 1 M	¥ 9 M
Other Current Assets	¥ 110 M	¥ 199 M
Current Assets	¥ 7 B	¥ 5 B
Tangible Assets	¥ 68 M	¥ 101 M
Intangible Assets	¥ 26 M	¥ 20 M
Investment etc.	¥ 501 M	¥ 288 M
Total Assets	¥ 8 B	¥ 5 B
Current Liabilities	¥ 204 M	¥ 183 M
Fixed Liabilities	¥ 470 K	¥ 7 M
Liabilities with interest	-	-
Net Assets	¥ 8 B	¥ 5 B
Capital stock	¥ 8 B	¥ 8 B
Capital surplus etc.	¥ -315 M	¥ -3 B
Liabilities and net assets	¥ 8 B	¥ 5 B
Indicator	2011-12-31	2012-12-31
Income statement
Sales	¥ 684 M	¥ 28 M
Cost of Sales	¥ 2 B	¥ 2 B
Gross profit	¥ -1 B	¥ -2 B
Other income	¥ 55 M	¥ 27 M
SG&A	-	-
Other expenses	¥ 45 M	¥ 292 M
Net income	¥ -1 B	¥ -2 B
Operating income	¥ -1 B	¥ -2 B
Ordinary Income	¥ -1 B	¥ -2 B
EBITDA	¥ -1 B	¥ -2 B
Income before income taxes	¥ -1 B	¥ -2 B
Depreciation	¥ 19 M	¥ 28 M
R&D expenses	-	-
Income taxes	-	-
Indicator	2011-12-31	2012-12-31
Cash flow statement
Operating CF	¥ -1 B	¥ -2 B
Investment CF	¥ -3 B	¥ 3 B
Financial CF	¥ 5 B	-
Foreign Exchange Effects	¥ -11 M	¥ 4 K
Net Change in Cash	¥ 484 M	¥ 1 B
Free CF	¥ -5 B	¥ 1 B
Capital expenditures	¥ -6 M	¥ -52 M
Cash dividends paid	-	-
Repayment loans	-	-
Indicator	2011-12-31	2012-12-31
Shareowners' equity
Issuance of new shares	¥ 5 B	-
Dividends from surplus	-	-
Net income	¥ -1 B	¥ -2 B
Purchase of treasury stock	-	-
Other Change in Stockholders Equity	¥ -1 K	-
Other Change in Net Assets	¥ -20 M	¥ 41 M
Net Change in Net Assets	¥ 3 B	¥ -2 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: RaQualia Pharma (Annual )

Statement Type

Annual : RaQualia Pharma

First quarter : RaQualia Pharma

Second quarter : RaQualia Pharma

Third quarter : RaQualia Pharma

Analysis Menu

Outline : RaQualia Pharma

Statement : RaQualia Pharma

Rating : RaQualia Pharma

Indicator : RaQualia Pharma

Download : RaQualia Pharma

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Aichi - EDIUNET Prefectures

Aichi知多郡 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
RaQualia Pharma	4579	OSE JASDAQ	Chemicals	12	Annual	BB

Related Company

Kawaguchi Chemical Industry (Sales ¥ 6 B)

シンバイオ製薬 (Sales ¥ 1 B)

Nippon Shikizai (Sales ¥ 6 B)

日本化学工業 (Sales ¥ 27 B)

RaQualia Pharma (Sales ¥ 28 M)

KAWAKAMI PAINT MFG. (Sales ¥ 5 B)

Sosei Group (Sales -)

Chiome Bioscience (Sales ¥ 324 M)

Carna Biosciences (Sales ¥ 464 M)

廣貫堂 (Sales ¥ 10 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .